@chanelgetshealthyish's GLP-1 mistakes advice, fact-checked

A TikTok creator with 362.9K views shares three mistakes to avoid when starting GLP-1 medications like semaglutide or tirzepatide. While we can't see the specific advice given, common GLP-1 mistake warnings circulating on social media range from helpful to misleading.

What mistakes do people typically warn about with GLP-1s?

The most common TikTok advice covers dosing errors, food timing, and unrealistic expectations. Some creators correctly warn against skipping the gradual dose escalation protocol.

Others focus on eating too much or the wrong foods, though the evidence here is mixed. The STEP 1 trial (Wilding et al., NEJM, 2021) didn't require specific dietary restrictions beyond standard counseling, yet participants lost 14.9% of body weight on 2.4mg semaglutide.

A third category warns about expecting immediate results. The STEP trials show meaningful weight loss typically begins around week 4-8, with peak effects at 68 weeks.

Do GLP-1 medications actually require special food rules?

Not really, despite what many TikTok creators suggest. The clinical trials that led to FDA approval didn't mandate specific diets or eating windows.

The STEP 1 participants received standard lifestyle counseling about a 500-calorie deficit but weren't told to avoid certain foods. They still achieved substantial weight loss. The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) using tirzepatide 15mg showed 20.9% weight loss with similar basic dietary guidance.

Some people do report that fatty foods worsen nausea, a common side effect. But this is individual tolerance, not a requirement for the medication to work.

What about dosing mistakes?

This is where TikTok creators often get it right. The dose escalation schedule isn't optional.

Semaglutide starts at 0.25mg weekly for 4 weeks, then increases every 4 weeks: 0.5mg, 1.0mg, 1.7mg, up to 2.4mg maintenance. Skipping steps or rushing the timeline increases side effects without improving results.

The STEP 4 trial (Rubino et al., NEJM, 2021) showed what happens when people stop: participants regained two-thirds of their lost weight within a year. That's not a dosing mistake, but it shows these medications work only while you're taking them.

What should you actually know about starting GLP-1s?

The real mistakes aren't usually about food rules or timing. They're about expectations and medical oversight.

First, these aren't quick fixes. The STEP trials ran 68-104 weeks. Second, side effects like nausea affect 40-50% of people initially but usually improve. Third, you need ongoing medical supervision, not just TikTok advice.

The most important factor is staying on the medication long-term. In real-world studies, about 70% of people discontinue within a year, often due to cost or side effects. That's the mistake that actually matters for weight maintenance.